JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312762

重组Alexa Fluor® 568荧光Anti-PMP22抗体[EPR23112-110]

Alexa Fluor® 568 Anti-PMP22 antibody [EPR23112-110]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal PMP22 antibody - conjugated to Alexa Fluor® 568.

查看别名

GAS3, PMP22, Peripheral myelin protein 22, PMP-22, Growth arrest-specific protein 3, GAS-3

不同偶联物与剂型 (10)

  • Unconjugated

    Anti-PMP22 antibody [EPR23112-110]

  • 660 APC

    APC Anti-PMP22 antibody [EPR23112-110]

  • HRP

    HRP Anti-PMP22 antibody [EPR23112-110]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-PMP22 antibody [EPR23112-110]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-PMP22 antibody [EPR23112-110]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-PMP22 antibody [EPR23112-110]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-PMP22 antibody [EPR23112-110]

  • 578 PE

    PE Anti-PMP22 antibody [EPR23112-110]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-PMP22 antibody [EPR23112-110]

  • Carrier free

    Anti-PMP22 antibody [EPR23112-110] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR23112-110

亚型

IgG

偶联物

Alexa Fluor® 568

激发波长/发射波长

Ex: 578nm, Em: 603nm

不含载体蛋白

No

应用

Antibody Labelling, Target Binding Affinity

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column
style
left-column

产品详情

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

style
left-column

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle|Store in the dark
style
left-column

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The 'PMP22 protein' also known as Peripheral Myelin Protein 22 is an essential component of the myelin sheath in the peripheral nervous system. It has a molecular weight of approximately 22 kDa. The protein is highly expressed in Schwann cells which are responsible for forming myelin around peripheral nerves. PMP22 contains four transmembrane domains playing a role in its structural function in the membrane.
Biological function summary

The 'PMP22' serves an important role in maintaining the integrity and functionality of the myelin sheath contributing to efficient nerve conduction. It is not typically part of a complex but interacts with other myelin proteins to support myelin compaction and stability. The protein's presence affects the cell cycle and myelination process important for the normal functioning of the peripheral nervous system.

Pathways

'PMP22 protein' plays roles in the Schwann cell differentiation and myelination pathways. It maintains correct peripheral nerve structure and function with connections to proteins such as MPZ (Myelin Protein Zero) which are also integral for proper nerve insulation. There are specific pathways where PMP22 downregulation or overexpression impacts the normal myelination cycle significant for peripheral nerve health.

'PMP 22' mutations or overexpression relate to Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). These conditions arise from gene dosage changes affecting nerve function where altered PMP22 protein levels lead to defective myelin formation. Interaction between PMP22 and proteins like connexin 32 shows further ties to demyelinating neuropathies emphasizing the gene-protein network involved in these disorders.
style
left-column
style
left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

靶点信息

Might be involved in growth regulation, and in myelinization in the peripheral nervous system.
See full target information PMP22
style
left-column
style
left-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。
style
left-column
style
right-column

关联产品

Select an associated product type
Alternative Version
Primary Antibodies

AB270407

Anti-PMP22 antibody [EPR23112-110] - BSA and Azide free

primary-antibodies

pmp22-antibody-epr23112-110-bsa-and-azide-free-ab270407

0

(0 reviews)

style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com